Law360, New York (April 28, 2015, 6:14 PM EDT) -- A Novartis AG unit convinced a Mississippi federal court Monday to dismiss an injury suit by a woman claiming its cataract lens contained a manufacturing defect, when the court ruled her claims were preempted because she didn't show the manufacturing process behind the lens wasn't approved by federal regulators.
U.S. District Judge Halil Suleyman Ozerden granted a motion to dismiss by Novartis unit Ciba Vision Corp., which manufactured the MemoryLens intraocular lens product that plaintiff Dovie Williams was implanted with in 1999 to treat her cataract condition. Judge Ozerden ruled that Williams had not shown any evidence to support her claims...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!